4
Shared Docs
4
Same-Page
11 / 4
Mentions
From: "Jeffrey E." <[email protected]> To: Subject: Fwd: Alzhe
i wanted to talk to him about Forwarded message From: Date: Sat, Apr 8, 2017 at 9:17 AM Subject: Fwd: Alzheimer's R&D updates - March 2017 To: Jeffrey Epstein <[email protected]> Begin forwarded message: From:- > Datil.8 2017 at 3:38:14 AM EDT To: < > Subject: FW: Alzheimer's R&D updates - March
Alzheimer's R&D updates - March 2017 To: Jeffrey Epstein <[email protected]> Begin forwarded message:
From: "Jeffrey E." <[email protected]> To: Subject: Fwd: A
to be very useful for screening, stratifying, and enrolling subjects for drug trials. Desikan RS, Fan CC, Wang Y, Schork Al, Cabral HJ, Cupples LA, Thompson WK, Besser L, Kukull WA, Holland D, Chen CH, Brewer 1B, Karow DS, Kauppi K, Witoelar A, Karch CM, Bonham LW, Yokoyama 1S, Rosen H1, Miller BL, Dillon W
15:25:52 +0000 Good morning - well received, thank you very much. Executive Assistant to Ronald S. Lauder RSL Management Corporation T F From: Jeffrey Epstein Date: Saturday, April 8, 2017 at 9:30 AM Subject: Fwd: Alzheimer's R&D updates - March 2017 Morning! please forward below to Ronald. ... tell him
R&D updates - March 2017 Morning! please forward below to Ronald. ... tell him Gates has decided to spend some money on alzhhiemers, that is what Jeffrey wanted to talk to him about Thanks, Forwarded message From: Date: Sat, Apr 8, 2017 at 9:17 AM Subject: Fwd: Alzheimer's R&D updates - March 201
RSL Management Corporation T F From: Jeffrey Epstein Date: Saturday, April 8, 2017 at 9:30 AM Subjec
ul for screening, stratifying, and enrolling subjects for drug trials. EFTA00449356 Desikan RS, Fan CC, Wang Y, Schork Al, Cabral HI, Cupples LA, Thompson WK, Besser L, Kukull WA, Holland D, Chen CH, Brewer JB, Karow DS, Kauppi K, Witoelar A, Karch CM, Bonham LW, Yokoyama JS, Rosen Hi, Miller BL, Dillon W
From: To: Jeffrey Epstein <[email protected]> Subject: Fwd: Alzheimer's R&D updates - March 2017 Date: Sat, 08 Apr 2017 13:17:58 +0000 Begin forwarded message: From: N
From: To: Jeffrey Epstein <[email protected]> Subject: Fwd: Alzheimer'
From: To: Jeffrey Epstein <[email protected]> Subject: Fwd: Al
to be very useful for screening, stratifying, and enrolling subjects for drug trials. Desikon RS, Fan CC, Wang Y, Schork Al, Cabral Hi, Cupples LA, Thompson WK, Besser L, Kukull WA, Holland D, Chen CH, Brewer .1B, Karow DS, Kouppi K, Witoelar A, Korch CM, Bonham LW Yokoyama JS, Rosen Hi, Miller BL, Dillon W
at, 08 Apr 2017 13:30:11 +0000 Morning! please forward below to.. ... tell him Gates has decided to spend some money on alzhhiemers, that is what Jeffrey wanted to talk to him about Thanks, Forwarded message From: Date: Sat, Apr 8, 2017 at 9:17 AM Subject: Fwd: Alzheimer's R&D updates - March 201
to be very useful for screening, stratifying, and enrolling subjects for drug trials. Desikan RS, Fan CC, Wang Y, Schork Al, Cabral HI, Cupples LA, Thompson WK, Besser L, Kukull WA, Holland D, Chen CH, Brewer JB, Karow DS, Kauppi K, Witoelar A, Karch CM, Bonham LW, Yokoyama JS, Rosen Hi, Miller BL, Dillon W
Entities connected to both Jeffrey Epstein and Thompson WK

Robert Gates
PERSON
Jacksonville
LOCATION
Edward Snowden
PERSON
Dillon
PERSON
St Louis
LOCATIONthe Mayo Clinic
ORGANIZATION
Neuron
ORGANIZATIONCabral
PERSONSchellenberg
PERSONWang J
PERSONArranz
PERSONVanden Eynden E
PERSONLiu et al
PERSONZhao N
PERSONWray S
PERSONAndo K
PERSONEspuny-Camacho
PERSON
J Neurosci
PERSONHoltzman DM
PERSONDavid Holtzman
PERSON